Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Marchex (MCHX) over the last 17 years, with Q3 2025 value amounting to -$110000.0.

  • Marchex's Cash from Financing Activities fell 1224.49% to -$110000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$46000.0, marking a year-over-year increase of 8445.95%. This contributed to the annual value of -$307000.0 for FY2024, which is 9187.5% down from last year.
  • Latest data reveals that Marchex reported Cash from Financing Activities of -$110000.0 as of Q3 2025, which was down 1224.49% from -$79000.0 recorded in Q2 2025.
  • In the past 5 years, Marchex's Cash from Financing Activities registered a high of $276000.0 during Q4 2021, and its lowest value of -$1.5 million during Q4 2022.
  • For the 5-year period, Marchex's Cash from Financing Activities averaged around -$74684.2, with its median value being -$10000.0 (2023).
  • As far as peak fluctuations go, Marchex's Cash from Financing Activities surged by 56521.74% in 2021, and later crashed by 123750.0% in 2023.
  • Quarter analysis of 5 years shows Marchex's Cash from Financing Activities stood at $276000.0 in 2021, then plummeted by 638.04% to -$1.5 million in 2022, then surged by 99.33% to -$10000.0 in 2023, then plummeted by 110.0% to -$21000.0 in 2024, then tumbled by 423.81% to -$110000.0 in 2025.
  • Its Cash from Financing Activities was -$110000.0 in Q3 2025, compared to -$79000.0 in Q2 2025 and $164000.0 in Q1 2025.